Tyrosine-kinase inhibitors and patient-reported outcomes in chronic myeloid leukemia: A systematic review
Author:
Funder
Bristol-Myers Squibb
Novartis
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference29 articles.
1. Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology;Kris;J Clin Oncol,2010
2. Front-line and salvage therapies with tyrosine kinase inhibitors and other treatments in chronic myeloid leukemia;Cortes;J Clin Oncol,2011
3. Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008;Bjorkholm;J Clin Oncol,2011
4. Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib;Gambacorti-Passerini;J Natl Cancer Inst,2011
5. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia;Kantarjian;N Engl J Med,2010
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease;Nature Communications;2024-01-22
2. Measuring chronic myeloid leukaemia TKI-related toxic effects in the real world: a systematic review and critical assessment of content validity of patient-reported outcome measures;The Lancet Haematology;2023-10
3. A Pragmatic Approach to Managing Long-Term Adverse Effects in Chronic Myeloid Leukemia Treatment;Current Hematologic Malignancy Reports;2023-05-16
4. The Effects of Tyrosine Kinase Inhibitors (TKIs) in Monotherapy and with Add-on Treatments on Health-related Quality of Life of People with Chronic Myeloid Leukemia: A Systematic Review of Randomized-Controlled Trials;Clinical Practice & Epidemiology in Mental Health;2023-01-05
5. Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia;Haematologica;2022-05-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3